{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:55:52Z","timestamp":1790391352907,"version":"4.1.0"},"reference-count":40,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"unspecified","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Action Against Age-related Macular Degeneration","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2024,3,6]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Despite significant advances in clinical care and understanding of the underlying pathophysiology, age-related macular degeneration (AMD)\u2014a major cause of global blindness\u2014lacks effective treatment to prevent the irreversible degeneration of photoreceptors leading to central vision loss. Limited studies suggest phosphodiesterase type 5 (PDE5) inhibitors, such as sildenafil, may prevent AMD by increasing retinal blood flow. This study explores the potential association between sildenafil use and AMD risk in men with erectile dysfunction using UK data.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>Using the UK\u2019s IQVIA Medical Research Data, the study analysed 31 575 men prescribed sildenafil for erectile dysfunction and no AMD history from 2007 to 2015, matched with a comparator group of 62 155 non-sildenafil users in a 1:2 ratio, over a median follow-up of approximately three years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The primary outcome was the incidence of AMD in the two groups. The study found no significant difference in AMD incidence between the sildenafil users and the non-users, with an adjusted hazard ratio (HR) of 0.99 (95% CI 0.84 to 1.16), after accounting for confounders such as age, ethnicity, Townsend deprivation quintile, body mass index category, and diagnosis of hypertension and type 2 diabetes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The study results indicated no significant association between sildenafil use and AMD prevention in UK men with erectile dysfunction, suggesting sildenafil\u2019s protective effect on AMD is likely insignificant.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjophth-2023-001525","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T10:55:18Z","timestamp":1710500118000},"page":"e001525","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Association of sildenafil use with age-related macular degeneration: a retrospective cohort study"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7435-0658","authenticated-orcid":false,"given":"Ji Eun Diana","family":"Han","sequence":"first","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradhaa","family":"Subramanian","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Hwa","family":"Lee","sequence":"additional","affiliation":[{"name":"Action Against Age-Related Macular Degeneration, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Coker","sequence":"additional","affiliation":[{"name":"Action Against Age-Related Macular Degeneration, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair K","family":"Denniston","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospitals Birmingham NHSFT, Birmingham, UK"},{"name":"Moorfields Eye Hospital NHS Foundation Trust and Institute of Ophthalmology, University College London, London, UK"},{"name":"Health Data Research UK (HDRUK), London, UK"},{"name":"Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK"},{"name":"National Institute for Health and Care Research Birmingham Biomedical Research Centre, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnarajah","family":"Nirantharakumar","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"},{"name":"Health Data Research UK (HDRUK), London, UK"},{"name":"National Institute for Health and Care Research Birmingham Biomedical Research Centre, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Jaime","family":"Adderley","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"},{"name":"National Institute for Health and Care Research Birmingham Biomedical Research Centre, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,3,15]]},"reference":[{"key":"2025090110134753000_9.1.e001525.1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(13)70145-1"},{"key":"2025090110134753000_9.1.e001525.2","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7525-4-97","article-title":"Quality of life in age-related macular degeneration: a review of the literature","volume":"4","author":"Mitchell","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"2025090110134753000_9.1.e001525.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.05.028"},{"key":"2025090110134753000_9.1.e001525.4","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8374647"},{"key":"2025090110134753000_9.1.e001525.5","unstructured":"Apellis Pharmaceuticals, Inc . SYFOVRE TM (Pegcetacoplan injection), for intravitreal use. 2023. Available: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/217171s000lbl.pdf"},{"key":"2025090110134753000_9.1.e001525.6","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-318452"},{"key":"2025090110134753000_9.1.e001525.7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/ICU.0000000000000657","article-title":"Age-related macular degeneration therapy: a review","volume":"31","author":"Ammar","year":"2020","journal-title":"Curr Opin Ophthalmol"},{"key":"2025090110134753000_9.1.e001525.8","unstructured":"Drugs.com . Syfovre prices, coupons, Copay & patient assistance. Available: https:\/\/www.drugs.com\/price-guide\/syfovre,\u00a0https:\/\/www.facebook.com\/Drugscom [Accessed 16 May 2023]."},{"key":"2025090110134753000_9.1.e001525.9","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1038\/s41433-023-02571-3","article-title":"Exploring patient acceptability of emerging intravitreal therapies for geographic atrophy: a mixed-methods study","volume":"37","author":"Enoch","year":"2023","journal-title":"Eye (Lond)"},{"key":"2025090110134753000_9.1.e001525.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31550-2"},{"key":"2025090110134753000_9.1.e001525.11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218242","article-title":"Neovascular age-related macular degeneration: therapeutic management and new-upcoming approaches","volume":"21","author":"Ricci","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025090110134753000_9.1.e001525.12","article-title":"Age-related macular degeneration: anti-vascular endothelial growth factor treatment","volume":"2016","author":"Arnold","year":"2016","journal-title":"BMJ Clin Evid"},{"key":"2025090110134753000_9.1.e001525.13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.drudis.2018.11.022","article-title":"The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions","volume":"24","author":"Polamreddy","year":"2019","journal-title":"Drug Discov Today"},{"key":"2025090110134753000_9.1.e001525.14","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2021-319641"},{"key":"2025090110134753000_9.1.e001525.15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/jamaophthalmol.2020.6331","article-title":"Association of metformin use with age-related macular degeneration: a case-control study","volume":"139","author":"Blitzer","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"2025090110134753000_9.1.e001525.16","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1111\/bcp.15366","article-title":"Angiotensin\u2010Converting enzyme inhibitors and risk of age\u2010related macular degeneration in individuals with hypertension","volume":"88","author":"Subramanian","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"2025090110134753000_9.1.e001525.17","doi-asserted-by":"crossref","first-page":"8564818","DOI":"10.1155\/2022\/8564818","article-title":"The relationship between statin and risk of age-related macular degeneration: a systematic review and meta-analysis","volume":"2022","author":"Memarzadeh","year":"2022","journal-title":"J Ophthalmol"},{"key":"2025090110134753000_9.1.e001525.18","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2030"},{"key":"2025090110134753000_9.1.e001525.19","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.627229","article-title":"New approaches in oncology for repositioning drugs: the case of PDE5 inhibitor Sildenafil","volume":"11","author":"Cruz-Burgos","year":"2021","journal-title":"Front Oncol"},{"key":"2025090110134753000_9.1.e001525.20","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2013-303143"},{"key":"2025090110134753000_9.1.e001525.21","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-1050"},{"key":"2025090110134753000_9.1.e001525.22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-41509-2","article-title":"Vascular response to sildenafil citrate in aging and age-related macular degeneration","volume":"9","author":"Yiu","year":"2019","journal-title":"Sci Rep"},{"key":"2025090110134753000_9.1.e001525.23","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2203"},{"key":"2025090110134753000_9.1.e001525.24","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1335"},{"key":"2025090110134753000_9.1.e001525.25","doi-asserted-by":"publisher","DOI":"10.14236\/jhi.v19i4.820"},{"key":"2025090110134753000_9.1.e001525.26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.300.6732.1092"},{"key":"2025090110134753000_9.1.e001525.27","unstructured":"Dictionary of medicines and devices (dm+d) | NHSBSA. Available: https:\/\/www.nhsbsa.nhs.uk\/pharmacies-gp-practices-and-appliance-contractors\/dictionary-medicines-and-devices-dmd [Accessed 17 May 2023]."},{"key":"2025090110134753000_9.1.e001525.28","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3368"},{"key":"2025090110134753000_9.1.e001525.29","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1688"},{"key":"2025090110134753000_9.1.e001525.30","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14813"},{"key":"2025090110134753000_9.1.e001525.31","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900905"},{"key":"2025090110134753000_9.1.e001525.32","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-020-00677-6"},{"key":"2025090110134753000_9.1.e001525.33","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-16271"},{"key":"2025090110134753000_9.1.e001525.34","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1520-6300(1996)8:6&lt;786::aid-ajhb11&gt;3.0.co;2-i"},{"key":"2025090110134753000_9.1.e001525.35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","article-title":"Age-related macular degeneration","volume":"7","author":"Fleckenstein","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2025090110134753000_9.1.e001525.36","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2019-314422"},{"key":"2025090110134753000_9.1.e001525.37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108196","article-title":"Diabetes mellitus and risk of age-related macular degeneration: a systematic review and meta-analysis","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS ONE"},{"key":"2025090110134753000_9.1.e001525.38","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j5544","article-title":"Viagra will be available over counter","volume":"359","author":"Kmietowicz","year":"2017","journal-title":"BMJ"},{"key":"2025090110134753000_9.1.e001525.39","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)01338-7"},{"key":"2025090110134753000_9.1.e001525.40","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1743-6109.2012.02972.x","article-title":"The global online sexuality survey (GOSS): the United States of America in 2011 chapter II: phosphodiesterase inhibitors utilization among English speakers","volume":"10","author":"Shaeer","year":"2013","journal-title":"J Sex Med"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2023-001525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T17:13:57Z","timestamp":1756746837000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2023-001525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,3,15]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/bmjophth-2023-001525"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2023-001525","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}